Latest filing published 06 Sept 2019 for Innovation Pharmaceuticals Inc., €50k.
Insider track record
Arthur Peter Bertolino: trading record in brief
Arthur Peter Bertolino is a declared insider at 2 companies; the most frequent names are Revance Therapeutics, Inc. and Innovation Pharmaceuticals Inc. The record holds 12 filings, for trades running from 2 September 2014 to 1 September 2019.
Every open-market trade on record is a sale: 4 sales worth €284k. Other entries cover 8 share grants.
The record was last updated on 6 September 2019 with a share grant (€50k) in Innovation Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Arthur Peter Bertolino
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 421,611 shares@ US$0.1339.8% of flowClass A Common StockSEC:0001123292-19-001106:0
- 218,946 shares@ US$0.4060.2% of flowClass A Common StockSEC:0001123292-18-001005:0
- 1,066,667 shares0Class A Common StockSEC:0001123292-18-000972:0
- 1,066,667 shares0Class A Common StockSEC:0001123292-17-001401:0
- 1,066,667 shares0Common StockSEC:0001477932-16-011219:0
- 5,425 shares@ US$39.11Common StockSEC:0001209191-15-080796:0
- 36 shares@ US$39.55Common StockSEC:0001209191-15-080796:1
- 2,277 shares@ US$39.11Common StockSEC:0001209191-15-080796:2
- 15 shares@ US$39.55Common StockSEC:0001209191-15-080796:3
- 3,699 shares@ US$30.48Common StockSEC:0001209191-15-069655:0
- 6,078 shares0Common StockSEC:0001209191-15-008043:0
- 39,375 shares0Common StockSEC:0001209191-14-055321:0
12 of 12 declarations
